Aimed to provide integrated solutions for biomedical research with new introduced product lines (lab supplies, high-throughput processing instruments, lab automation system,etc).
During the pandemic, provides featured raw materials for COVID-19 diagnosis, including antibodies, proteins, and molecular reagents.
Accelerating our R&D in recombinant monoclonal antibodies based on proprietary single B cell based antibody development platform SMabTM, and innovative genomic research products based on molecular enzyme and NGS reagents development platform.
Established multiple R&D Centers with different focuses to support technical innovation and product development.
Provides variety of custom services including antibody development, immunoassay development, multiplex assay, protein expression and purification, etc.
In 2011, ABclonal initially started the business in antibody development and production.
